Apr 23, 2014 at 10:40 | Source: Moneycontrol.com
Dr Reddys Laboratories has launched Fenofibrate Capsules, USP 43 mg and 130 mg a therapeutic equivalent generic version of ANTARA capsules, in the US market on April 22, 2014, approved by the USFDA.
Apr 23, 2014 at 08:25 | Source: Moneycontrol.com
Indian ADRs ended mostly lower on Tuesday. Wipro slipped 4.94 percent and ICICI Bank declined 1.29 percent.
Apr 22, 2014 at 11:17 | Source: CNBC-TV18
SP Tulsian of sptulsian.com feels that Sun Pharmaceutical Industries may slip below Rs 600.
Apr 22, 2014 at 08:29 | Source: Moneycontrol.com
Indian ADRs ended mostly lower on Monday. Dr Reddy's Laboratories gained 0.57 percent and ICICI Bank was down 0.38 percent.
Apr 21, 2014 at 14:42 | Source: CNBC-TV18
Nischal Maheshwari of Edelweiss Financial Services is neutral on pharmaceutical space.
Apr 21, 2014 at 13:18 | Source: Moneycontrol.com
Nifty is bound in a trading range of 6675-6828 points and many people will interpret this as a head and shoulder pattern, albeit a short term topping pattern.
Apr 18, 2014 at 14:32 | Source: Reuters
Medicines produced in India, which supplies about 40 percent of generic and over-the-counter drugs sold in the United States, have come under increased scrutiny by the Food and Drug Administration over the past year.
Apr 17, 2014 at 08:23 | Source: Moneycontrol.com
Indian ADRs ended mixed on Wednesday. Dr Reddy's Laboratories shed 1.61 percent and Tata Motors advanced 2 percent.
Apr 16, 2014 at 10:18 | Source: Moneycontrol.com
Dr Reddys Laboratories has launched Eszopiclone Tablets (C-IV) 1 mg, 2 mg and 3 mg, a therapeutic equivalent generic version of LUNESTA tablets C-IV in the US market on April 15, 2014, following the approval by the USFDA.
Apr 16, 2014 at 08:28 | Source: Moneycontrol.com
Indian ADRs ended mostly lower on Tuesday. Wipro gained more than 2 percent, while Infosys plunged 4.68 percent.